EE+ POEM Archive
Empagliflozin reduces hospitalization for heart failure with preserved ejection fraction (NNT = 59 per year), but not mortality outcomes (EMPEROR-Preserved)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Empagliflozin Reduces Hospitalization for Heart Failure With Preserved Ejection Fraction (NNT = 59 Per Year), but Not Mortality Outcomes (EMPEROR-Preserved)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315513/all/Empagliflozin_reduces_hospitalization_for_heart_failure_with_preserved_ejection_fraction__NNT_=_59_per_year___but_not_mortality_outcomes__EMPEROR_Preserved_.
Empagliflozin reduces hospitalization for heart failure with preserved ejection fraction (NNT = 59 per year), but not mortality outcomes (EMPEROR-Preserved). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315513/all/Empagliflozin_reduces_hospitalization_for_heart_failure_with_preserved_ejection_fraction__NNT_=_59_per_year___but_not_mortality_outcomes__EMPEROR_Preserved_. Accessed October 14, 2024.
Empagliflozin reduces hospitalization for heart failure with preserved ejection fraction (NNT = 59 per year), but not mortality outcomes (EMPEROR-Preserved). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315513/all/Empagliflozin_reduces_hospitalization_for_heart_failure_with_preserved_ejection_fraction__NNT_=_59_per_year___but_not_mortality_outcomes__EMPEROR_Preserved_
Empagliflozin Reduces Hospitalization for Heart Failure With Preserved Ejection Fraction (NNT = 59 Per Year), but Not Mortality Outcomes (EMPEROR-Preserved) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315513/all/Empagliflozin_reduces_hospitalization_for_heart_failure_with_preserved_ejection_fraction__NNT_=_59_per_year___but_not_mortality_outcomes__EMPEROR_Preserved_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Empagliflozin reduces hospitalization for heart failure with preserved ejection fraction (NNT = 59 per year), but not mortality outcomes (EMPEROR-Preserved)
ID - 1315513
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315513/all/Empagliflozin_reduces_hospitalization_for_heart_failure_with_preserved_ejection_fraction__NNT_=_59_per_year___but_not_mortality_outcomes__EMPEROR_Preserved_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
